Department of Internal Medicine, Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.
J Clin Gastroenterol. 2013 May-Jun;47(5):432-6. doi: 10.1097/MCG.0b013e31826faf2b.
Endoscopic mucosal resection (EMR) has been the endoscopic treatment of choice for rectal carcinoid tumors <10 mm in size. Endoscopic submucosal dissection (ESD) may cause more severe complications, longer operation time, and higher cost than EMR.
: To compare EMR using band ligation (EMR-B) method with ESD for the endoscopic treatment of rectal carcinoid tumors.
From November 2008 to September 2011, we enrolled consecutive patients with rectal carcinoid tumors <10 mm in diameter and without lymph node enlargement. Rate of complete resection rate, incidence of complications, and length of procedures were evaluated.
Sixty patients were enrolled (31 ESD cases and 29 EMR-B cases). The mean age was 48.03±13.09 years. Both groups had similar mean tumor diameter (EMR-B 4.34±1.75 vs. ESD 5.22±2.09 mm; P=0.084). Resection time was longer in the ESD group than in the EMR-B group (15.09±5.73 vs. 6.37±5.52 min; P<0.001). The complete resection rate was 80.6% (25 of 31) in the ESD group and 82.8% (24 of 29) in the EMR-B group (P=0.833). In incomplete resection cases, neither local recurrence nor distant metastasis was detected during the follow-up period.
Compared with ESD, EMR-B resulted in a comparable histologically complete resection rate and took less time to perform. Given the advantages of easier and shorter procedure time, EMR-B may be considered the treatment of choice for small rectal carcinoid tumors.
内镜下黏膜切除术(EMR)一直是直径<10mm 直肠类癌的首选内镜治疗方法。内镜黏膜下剥离术(ESD)可能比 EMR 引起更严重的并发症、更长的手术时间和更高的成本。
比较套扎法内镜下黏膜切除术(EMR-B)与 ESD 治疗直肠类癌的疗效。
我们连续纳入了 2008 年 11 月至 2011 年 9 月直径<10mm 且无淋巴结肿大的直肠类癌患者。评估完全切除率、并发症发生率和手术时间。
共纳入 60 例患者(ESD 组 31 例,EMR-B 组 29 例)。患者平均年龄为 48.03±13.09 岁。两组肿瘤平均直径相似(EMR-B 组为 4.34±1.75mm,ESD 组为 5.22±2.09mm;P=0.084)。ESD 组的切除时间长于 EMR-B 组(15.09±5.73min vs. 6.37±5.52min;P<0.001)。ESD 组完全切除率为 80.6%(25/31),EMR-B 组为 82.8%(24/29)(P=0.833)。在不完全切除的病例中,在随访期间均未发现局部复发或远处转移。
与 ESD 相比,EMR-B 可获得相当的组织学完全切除率且操作时间更短。鉴于其具有操作更简单、时间更短的优势,EMR-B 可能是直肠类癌的首选治疗方法。